US EditionBoston Scientific’s Early ACURATE PRIME Registry Data Presented - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Boston Scientific’s Early ACURATE PRIME Registry Data Presented - Cardiac Interventions Today
May 27, 2025—Boston Scientific recently announced data from the Early ACURATE PRIME Registry, which is evaluating the Acurate Prime aortic valve system. Boston Scientific noted that the findings are the first large, real-world clinical data on the company’s latest transcatheter aortic valve replacement (TAVR) device after its approval and launch in Europe last year. On August 27, 2024, the company announced CE Mark approval of the self-expanding…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
